Discovery & Innovation

This is Part 2 in a three-part series on patient-centered outcomes. (Check out Part 1 and Part 3). A personalized medicine approach to clinical...

This is Part 1 in a three-part series on patient-centered outcomes. (Check out Part 2 and Part 3). In different regulatory and research settings...

Targeted based drug discovery has been a mainstay of pharmaceutical pipelines for the last 20 years. Identifying and validating novel drug...

Steve Blank wrote an excellent 3 part blog series last week. We covered Part 1 which described the challenges Life Science companies face in...

Interesting news for those thinking about personalized medicine and drug development: children born to mothers after bariatric gastrointestinal...

Life science companies are known to be one of the most expensive and difficult to start up. We look for an answer as to why in an excellent article...

Almost weekly in the news there is an article about a new scientific breakthrough and how animal models were instrumental in making this discovery...

An oncogene is a gene that can potentially cause cancer. RAS is a common class of oncogene and the focus of researchers worldwide, particularly at...

While the mouse may be king, it’s not the only show in town. Beyond the mouse, several other species are used as animal models of human disease...

As previously discussed, there is great value in using in vivo models such as genetically modified mice and xenograft models for oncology research...